We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $455M
1-Year Est. Return 218.66%
This Fund
S&P 500
This Quarter Est. Return
+16.65%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$308M
AUM Growth
+$25.4M
Cap. Flow
-$7.32M
Cap. Flow %
-2.38%
Top 10 Hldgs %
22.74%
Holding
140
New
27
Increased
41
Reduced
24
Closed
42

Top Buys

Rank Stock Value
1
WING icon
Wingstop
WING
+$7.21M
2
MTZ icon
MasTec
MTZ
+$5.53M
3
BLD
TopBuild
BLD
+$5.1M
4
AYX
Alteryx Inc
AYX
+$4.88M
5
NTRA icon
Natera
NTRA
+$4.57M

Sector Composition

Rank Sector Weight
1 Industrials 23.7%
2 Healthcare 23.53%
3 Technology 18.33%
4 Consumer Discretionary 17.79%
5 Consumer Staples 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WING icon
1
Wingstop
WING
$2.97B
$8.39M 2.73%
+88,540
New +$7.21M
EVOP
2
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$7.82M 2.54%
248,060
+88,960
+56% +$2.59M
RGEN icon
3
Repligen
RGEN
$9.46B
$7.65M 2.49%
89,040
+31,905
+56% +$2.17M
FOXF icon
4
Fox Factory Holding Corp
FOXF
$905M
$7.23M 2.35%
87,595
+6,290
+8% +$467K
TREE icon
5
LendingTree
TREE
$398M
$6.93M 2.25%
16,490
+3,320
+25% +$1.27M
PLNT icon
6
Planet Fitness
PLNT
$3.84B
$6.7M 2.18%
92,524
-19,835
-18% -$1.49M
PLAN
7
DELISTED
Anaplan, Inc.
PLAN
$6.6M 2.15%
130,825
+23,920
+22% +$989K
KNSL icon
8
Kinsale Capital Group
KNSL
$8.5B
$6.38M 2.07%
69,722
+30,855
+79% +$2.46M
TNDM icon
9
Tandem Diabetes Care
TNDM
$1.38B
$6.34M 2.06%
98,325
+51,070
+108% +$3.3M
JBTM
10
JBT Marel
JBTM
$6.11B
$5.91M 1.92%
48,775
+11,235
+30% +$1.21M
FRPT icon
11
Freshpet
FRPT
$3.38B
$5.88M 1.91%
129,315
-2,630
-2% -$119K
AYX
12
DELISTED
Alteryx Inc
AYX
$5.85M 1.9%
+53,575
New +$4.88M
MTZ icon
13
MasTec
MTZ
$19B
$5.77M 1.88%
+112,010
New +$5.53M
RBC icon
14
RBC Bearings
RBC
$15.5B
$5.76M 1.87%
34,555
+7,151
+26% +$1.01M
NTRA icon
15
Natera
NTRA
$47.3B
$5.72M 1.86%
+207,305
New +$4.57M
KMPR icon
16
Kemper
KMPR
$1.65B
$5.6M 1.82%
64,855
+29,055
+81% +$2.48M
BLD
17
DELISTED
TopBuild
BLD
$5.52M 1.79%
+66,715
New +$5.1M
COUP
18
DELISTED
Coupa Software Incorporated
COUP
$5.47M 1.78%
43,230
+15,335
+55% +$1.65M
OLLI icon
19
Ollie's Bargain Outlet
OLLI
$4.55B
$5.28M 1.72%
60,597
+7,405
+14% +$698K
PCRX icon
20
Pacira BioSciences
PCRX
$1.05B
$5.16M 1.68%
118,620
+46,615
+65% +$1.98M
MRCY icon
21
Mercury Systems
MRCY
$4.96B
$4.97M 1.62%
70,690
+24,265
+52% +$1.68M
HZNP
22
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.97M 1.62%
206,470
+52,275
+34% +$1.33M
NSP icon
23
Insperity
NSP
$1.98B
$4.75M 1.55%
38,920
+8,630
+28% +$1.04M
TNET icon
24
TriNet
TNET
$3.17B
$4.68M 1.52%
68,985
+26,745
+63% +$1.7M
ZS icon
25
Zscaler
ZS
$27.7B
$4.63M 1.5%
60,390
+51,050
+547% +$3.64M

Similar funds

Lisanti Capital Growth's Q2 2019 Portfolio in Review

As of Q2 2019, Lisanti Capital Growth held 140 positions worth $308M, up 9% from $282M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Lisanti Capital Growth's Q2 2019 filing shows 27 new, 41 increased, 24 reduced and 42 closed positions. Its largest new stake was Wingstop: 88,540 shares worth $8.39M. The largest sale was Merit Medical Systems, an estimated $5.53M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

  • Lisanti Capital Growth's largest Q2 2019 buy was Wingstop: 88,540 shares worth $8.39M.
  • Lisanti Capital Growth added most to Zscaler in Q2 2019, an estimated $3.64M increase.
  • Lisanti Capital Growth's biggest Q2 2019 reduction was Chart Industries, cutting an estimated $4.34M.
  • Lisanti Capital Growth fully exited Merit Medical Systems in Q2 2019, selling an estimated $5.53M.
  • Lisanti Capital Growth's ten largest holdings make up 23% of its $308M portfolio in Q2 2019.
  • Lisanti Capital Growth opened 27 new positions and closed 42 in Q2 2019.
  • Lisanti Capital Growth's portfolio value rose 9% quarter-over-quarter to $308M.

Based on Lisanti Capital Growth's 13F filing for Q2 2019, filed 5 Aug 2019.